Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy.

The journal of obstetrics and gynaecology research·2026
Same author

AMI-SSS01 portable phonocardiographic examination with AI-assisted assessment for detecting heart failure exacerbations in home-based medical care in Japanese primary care clinics: a study protocol for a randomised controlled feasibility trial.

BMJ open·2026
Same author

Characteristics and Outcomes of Multisystemic Inflammation in Patients Clinically Diagnosed With Non-COVID-19-Related Fulminant Myocarditis.

Circulation reports·2026
Same author

Papillary fibroelastoma arising in the left ventricular septum causing left ventricular outflow tract stenosis.

Journal of medical ultrasonics (2001)·2026
Same author

Association Between Severe Aortic Stenosis and Amyloid Deposition in the Myocardium of Patients With Wild-Type Transthyretin Cardiac Amyloidosis.

Circulation reports·2026
Same author

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Circulation·2026

Related Experiment Video

Updated: Jun 14, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Fatty liver incidence and predictive variables.

Akira Tsuneto1, Ayumi Hida, Nobuko Sera

  • 1Department of Cardiovascular Medicine, Course of Medical and Dental Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Sakamoto, Nagasaki, Japan. atsuneto@rerf.or.jp

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|April 10, 2010
PubMed
Summary
This summary is machine-generated.

Fatty liver incidence was 19.9 per 1000 person-years in Nagasaki atomic bomb survivors. Obesity, hypertriglyceridemia, and hypertension were identified as key predictors of fatty liver development.

More Related Videos

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Related Experiment Videos

Last Updated: Jun 14, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Area of Science:

  • Hepatology
  • Cardiovascular Epidemiology
  • Preventive Medicine

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a growing concern, often linked to metabolic syndrome and cardiovascular disease.
  • Understanding the incidence and predictors of fatty liver is crucial for early detection and intervention.

Purpose of the Study:

  • To determine the incidence of fatty liver disease in a cohort of Nagasaki atomic bomb survivors.
  • To identify key predictive variables associated with the development of fatty liver.

Main Methods:

  • A longitudinal study followed 1635 Nagasaki atomic bomb survivors without fatty liver at baseline using biennial abdominal ultrasonography until 2007.
  • Cox proportional hazard models and Wilcoxon rank-sum tests were employed to analyze predictive variables and longitudinal trends.
  • Potential predictors including obesity, lipid profiles, glucose metabolism, and hypertension were assessed.

Main Results:

  • A total of 323 new fatty liver cases were diagnosed, with an overall incidence of 19.9 per 1000 person-years.
  • Obesity (RR, 2.55), hypertriglyceridemia (RR, 1.92), and hypertension (RR, 1.31) were significant independent predictors of fatty liver in multivariate analysis.
  • Body mass index and serum triglycerides increased steadily prior to fatty liver diagnosis.

Conclusions:

  • Obesity, hypertriglyceridemia, and hypertension are significant predictors for the development of fatty liver.
  • These findings highlight the importance of managing metabolic risk factors for preventing fatty liver disease.
  • The study provides valuable epidemiological data on fatty liver incidence in a long-term survivor cohort.